Results 241 to 250 of about 1,846,702 (390)
Further Studies on the Effect of Neutralizing Antibody upon the Course of Herpes Simplex Infections in Tissue Culture [PDF]
Clayton E. Wheeler, Charles M. Canby
openalex +1 more source
A new amphipathic molecule, S416 is discovered, that locks the SARS‐CoV‐2 spike protein in its closed state, blocking viral entry. S416 acts as a molecular bolt, binding six sites: three between adjacent RBDs and three connecting NTDs to RBDs. This dual‐locking mechanism stiffens the spike structure and reduces its flexibility.
Shiliang Li+21 more
wiley +1 more source
To evaluate four novel SARS-CoV-2 neutralizing antibody assay kits' application in neutralizing antibodies of population. Questionnaires from the voluntary participating researchers and selected the qualified questionnaires to analyse.
Hui Zhen+9 more
doaj
Neutralizing antibodies to SARS-CoV-2 variants of concern: a pediatric surveillance study. [PDF]
Fraser DD+12 more
europepmc +1 more source
Observations on the Neutralizing Antibody Response to Group B Coxsackie Viruses in Patients with Central Nervous System Disease [PDF]
Edwin H. Lennette+3 more
openalex +1 more source
Advanced Pharmaceutical Nanotechnologies Applied for Chinese Herbal Medicines
This review offers a comprehensive overview of pharmaceutical nanotechnology strategies to address limitations associated with the complex material basis and relative mild therapeutic efficacy of Chinese herbal medicines, and summarizes the advantages of these strategies.
Jiameng Li+11 more
wiley +1 more source
Neutralizing Antibodies: Role in Immune Response and Viral Vector Based Gene Therapy. [PDF]
Tsaregorodtseva TS+8 more
europepmc +1 more source
Tackling COVID-19 with neutralizing monoclonal antibodies
D. Corti+3 more
semanticscholar +1 more source
Mechanisms of Virus Neutralization by Antibody
Klasse, P, Sattentau, Q
openaire +4 more sources
An Engineered Soluble Single‐Chain TCR Engager for KRAS‐G12V Specific Tumor Immunotherapy
This study develops a dimeric T cell receptor engager protein specific for tumor KRAS‐G12V mutation. The engager proteins are capable of mediating the formation of synapse between T cell and tumor cell and demonstrate substantial tumor suppression efficacy.
Keke Ma+14 more
wiley +1 more source